1-deoxycastanospermine: indolizidine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 195154 |
| MeSH ID | M0181024 |
| Synonym |
|---|
| 1-deoxycastanospermine |
| 115649-93-9 |
| (6s,7r,8r,8ar)-1,2,3,5,6,7,8,8a-octahydroindolizine-6,7,8-triol |
| 1-deoxy-6,8a-diepicastanospermine |
| 6,7,8-trihydroxyindolizidine |
| 1-deoxy-6-epicastanospermine |
| 1-deoxy-8a-epi-castanospermine |
| 6,7,8-trihydroxy-indolizidine |
| 1-deoxy-castanospermine |
| 6,7,8-indolizinetriol, octahydro-, (6s-(6alpha,7beta,8alpha,8aalpha))- |
| octahydroindolizine-6,7,8-triol |
| DTXSID00921781 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||